134 related articles for article (PubMed ID: 3104047)
21. [Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease].
Fitscha P; Simmet T; Peskar BA; Reuter H; Sinzinger H; Rogatti W; Tilsner V
Wien Klin Wochenschr; 1988 Jul; 100(14):477-81. PubMed ID: 3062905
[TBL] [Abstract][Full Text] [Related]
22. [Intra-arterial administration of prostaglandin E1 in occlusive arterial diseases].
Davidović L; Vranes M; Cernak I; Kostić D; Lovrić A; Sagić D; Lotina S
Srp Arh Celok Lek; 1992; 120(1-2):9-14. PubMed ID: 1641706
[TBL] [Abstract][Full Text] [Related]
23. [Intravenous and intra-arterial prostaglandin E1 treatment in patients with stage IIb arterial occlusive disease].
Rudofsky G
Vasa Suppl; 1988; 23():121-5. PubMed ID: 3206330
[No Abstract] [Full Text] [Related]
24. [Metabolism of intravenously administered prostaglandin E1 in patients with peripheral arterial occlusive disease].
Hesse WH; Rudofsky G; Peskar BA
Wien Klin Wochenschr; 1991; 103(18):554-7. PubMed ID: 1750222
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E1 in peripheral vascular disease: a PET study of muscular blood flow.
Schellong SM; Burchert W; Böger RM; Creutzig A; Hundeshagen H; Alexander K
Scand J Clin Lab Invest; 1998 Apr; 58(2):109-17. PubMed ID: 9587162
[TBL] [Abstract][Full Text] [Related]
26. Effects of intravenous and intra-arterial infusions of prostaglandin E1 on canine hindlimb blood flow distribution.
Lynch TG; Hobson RW; Barbalinardo JP; Kerr JC
Surgery; 1984 Jul; 96(1):35-41. PubMed ID: 6539953
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of continuous infusion of prostaglandin E1 through the superior mesenteric artery against ischemic liver cell necrosis after hepatic artery occlusion.
Kato T; Sato T; Kurokawa T; Nanjo H; Asanuma Y; Koyama K
Transplantation; 2003 Nov; 76(9):1340-5. PubMed ID: 14627913
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic efficacy of intravenously applied prostaglandin E1.
Scheffler P; de la Hamette D; Leipnitz G
Vasa Suppl; 1989; 28():19-25. PubMed ID: 2609240
[TBL] [Abstract][Full Text] [Related]
29. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
Horch R; Krönung G
Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
[No Abstract] [Full Text] [Related]
30. [Reflex oximetry for evaluating blood redistribution in patients with arterial occlusive disease treated with PGE1].
Thum J; Caspary L; Creutzig A; Alexander K
Vasa Suppl; 1992; 35():39-41. PubMed ID: 1481056
[No Abstract] [Full Text] [Related]
31. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
Mlekusch W; Schillinger M; Sabeti S; Al-Awami M; Gschwandtner M; Minar E
Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
[TBL] [Abstract][Full Text] [Related]
32. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).
Otomo S; Mizushima Y; Aihara H; Yokoyama K; Watanabe M; Yanagawa A
Drugs Exp Clin Res; 1985; 11(9):627-31. PubMed ID: 3880049
[TBL] [Abstract][Full Text] [Related]
33. [Effect of prostaglandin E1 on function and deformability of neutrophilic granulocytes in patients with stage IV peripheral arterial occlusive disease].
Neumann FJ; Diehm C; Müller-Bühl U; Weiss T; Zimmermann R; Tillmanns H; Kübler W
Vasa Suppl; 1989; 27():40-1. PubMed ID: 2623539
[No Abstract] [Full Text] [Related]
34. Intensive vascular training in stage IIb of peripheral arterial occlusive disease. The additive effects of intravenous prostaglandin E1 or intravenous pentoxifylline during training.
Scheffler P; de la Hamette D; Gross J; Mueller H; Schieffer H
Circulation; 1994 Aug; 90(2):818-22. PubMed ID: 8044953
[TBL] [Abstract][Full Text] [Related]
35. [Duplex ultrasound measurement of hemodynamic parameters at rest and following arterial stenosis: effect of intra-arterial infusion therapy with prostaglandin E1].
Ranke C; Creutzig A; Alexander K
Vasa Suppl; 1989; 27():353-5. PubMed ID: 2696104
[No Abstract] [Full Text] [Related]
36. Effect of prolonged intra-arterial prostaglandin E1 infusion on canine arterial graft patency.
Cronenwett JL; Shapiro DM; Luce JL
Arch Surg; 1986 Jul; 121(7):760-4. PubMed ID: 3718209
[TBL] [Abstract][Full Text] [Related]
37. [Double-blind placebo-controlled study of the behavior of tcPO2 during intravenous infusion of prostaglandin E1 in patients with severe arterial occlusive disease].
Creutzig A; Caspary L; Alexander K
Vasa Suppl; 1992; 35():36-8. PubMed ID: 1481055
[No Abstract] [Full Text] [Related]
38. Prostaglandin E1 increases the blood flow rate of saphenous vein grafts in patients undergoing off-pump coronary artery bypass grafting.
Zhao L; Lu J; Wang C; Zhao W; Qing E; Ma J
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1208-11. PubMed ID: 24090805
[TBL] [Abstract][Full Text] [Related]
39. Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study.
Altstaedt HO; Berzewski B; Breddin HK; Brockhaus W; Bruhn HD; Cachovan M; Diehm C; Dörrler J; Franke CS; Gruss JD
Prostaglandins Leukot Essent Fatty Acids; 1993 Aug; 49(2):573-8. PubMed ID: 7692455
[TBL] [Abstract][Full Text] [Related]
40. [Prostaglandin E1 in stage III and IV arterial occlusive diseases. results of a multicenter study].
Trübestein G; Ludwig M; Diehm C; Gruss JD; Horsch S
Dtsch Med Wochenschr; 1987 Jun; 112(24):955-9. PubMed ID: 3297596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
